✦ LIBER ✦

An open label trial of rimantadine for treatment of patients who have failed or are unable to tolerate interferon therapy for hepatitis C

✍ Scribed by Kwo, PY; Fields, S; Born, L; Chalasani, N; Cho, W; Crabb, DW; Cummings, OW; Imperiale, T; Lumeng, L; McGill, J; Ness, R

Book ID: 122783131
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 170 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)85201-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with ribavirin plus

Combination therapy with ribavirin plus alpha interferon for the treatment of chronic hepatitis secondary to hepatitis C virus in patients who have failed treatment with alpha interferon

✍ Kwo, PY; Pound, DC; Fields, S; Glowinski, EA; Born, L; Chalasani, N; Cho, W; Cra 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Treatment of hepatitis C with daily indu

Treatment of hepatitis C with daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy in patients who are treatment naïve or have previously failed an interferon based therapy

✍ Lawitz, Eric J.; Kadakia, Shailesh C.; Cantu, Norma; Nader, Pierre; Cox, James; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

PEG-interfeoon α-2b + ribavirin for trea

PEG-interfeoon α-2b + ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon alfa or interferon a-2b + ribavirin therapy

✍ Sulkowski, Mark; Rothstein, Ken; Stein, Lawrence; Godofsky, Elliot; Goodman, Rus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Randomized trial of three different regi

Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-α monotherapy in Taiwan

✍ Wan-Long Chuang; Chia-Yen Dai; Shinn-Cherng Chen; Li-Po Lee; Zu-Yau Lin; Ming-Yu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Effectiveness of antipsychotic polypharm

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone

✍ Takefumi Suzuki; Hiroyuki Uchida; Koichiro Watanabe; Shinichiro Nakajima; Kensuk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective To evaluate the effectiveness of antipsychotic polypharmacy in a methodologically sound manner. ## Methods In this open‐label study, 17 patients with treatment‐refractory schizophrenia, who failed to respond to a sequential monotherapy with olanzapine, quetiapine and ris

Telaprevir for HIV/Hepatitis C Virus-Coi

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

✍ Cotte, L.; Braun, J.; Lascoux-Combe, C.; Vincent, C.; Valantin, M.-A.; Sogni, P. 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 525 KB